Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Making a lasting impact with sustained drug delivery in glaucoma
Ahmad Aref, MD, and Paul Singh, MD, offer a recap of their EyeCon 2021 presentation.
As ophthalmologists treat patients, drug compliance is always a concern, especially when a patient may be required to use drops daily. During the Ophthalmology Times® EyeCon 2021 program, Ahmad Aref, MD, and Paul Singh, MD, presented “Making a Lasting Impact With Sustained Drug Delivery in Glaucoma,” detailing some options available today. They offer a recap of that presentation.
Related Videos
Related Content
